rs147324438
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_173495.3(PTCHD1):āc.517A>Gā(p.Ile173Val) variant causes a missense change. The variant allele was found at a frequency of 0.000311 in 1,209,297 control chromosomes in the GnomAD database, including 2 homozygotes. There are 147 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00032 ( 0 hom., 14 hem., cov: 23)
Exomes š: 0.00031 ( 2 hom. 133 hem. )
Consequence
PTCHD1
NM_173495.3 missense
NM_173495.3 missense
Scores
4
13
Clinical Significance
Conservation
PhyloP100: 5.30
Genes affected
PTCHD1 (HGNC:26392): (patched domain containing 1) This gene encodes a membrane protein with a patched domain. The encoded protein is similar to Drosophila proteins which act as receptors for the morphogen sonic hedgehog. Deletions in this gene, which is located on the X chromosome, are associated with intellectual disability and autism (PMID: 21091464, PMID: 20844286). [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.03401667).
BP6
Variant X-23379756-A-G is Benign according to our data. Variant chrX-23379756-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 211971.We mark this variant Likely_benign, oryginal submissions are: {Benign=3, Uncertain_significance=2}. Variant chrX-23379756-A-G is described in Lovd as [Benign].
BS2
High Hemizygotes in GnomAd4 at 14 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTCHD1 | NM_173495.3 | c.517A>G | p.Ile173Val | missense_variant | 2/3 | ENST00000379361.5 | NP_775766.2 | |
PTCHD1 | XM_011545449.4 | c.517A>G | p.Ile173Val | missense_variant | 3/4 | XP_011543751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCHD1 | ENST00000379361.5 | c.517A>G | p.Ile173Val | missense_variant | 2/3 | 1 | NM_173495.3 | ENSP00000368666 | P1 | |
PTCHD1 | ENST00000456522.1 | c.159-12775A>G | intron_variant | 1 | ENSP00000406663 |
Frequencies
GnomAD3 genomes AF: 0.000324 AC: 36AN: 111016Hom.: 0 Cov.: 23 AF XY: 0.000422 AC XY: 14AN XY: 33200
GnomAD3 genomes
AF:
AC:
36
AN:
111016
Hom.:
Cov.:
23
AF XY:
AC XY:
14
AN XY:
33200
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000398 AC: 73AN: 183516Hom.: 1 AF XY: 0.000471 AC XY: 32AN XY: 67946
GnomAD3 exomes
AF:
AC:
73
AN:
183516
Hom.:
AF XY:
AC XY:
32
AN XY:
67946
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000310 AC: 340AN: 1098228Hom.: 2 Cov.: 31 AF XY: 0.000366 AC XY: 133AN XY: 363582
GnomAD4 exome
AF:
AC:
340
AN:
1098228
Hom.:
Cov.:
31
AF XY:
AC XY:
133
AN XY:
363582
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000324 AC: 36AN: 111069Hom.: 0 Cov.: 23 AF XY: 0.000421 AC XY: 14AN XY: 33263
GnomAD4 genome
AF:
AC:
36
AN:
111069
Hom.:
Cov.:
23
AF XY:
AC XY:
14
AN XY:
33263
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
50
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | PTCHD1: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 19, 2021 | This variant is associated with the following publications: (PMID: 20844286, 23871722) - |
Autism, susceptibility to, X-linked 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 29, 2014 | - - |
PTCHD1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 06, 2023 | The PTCHD1 c.517A>G variant is predicted to result in the amino acid substitution p.Ile173Val. This variant has been reported in at least one male patient with autism spectrum disorder/ intellectual disability and found in his unaffected mother and one of his unaffected sisters. Of note, this male patient was also heterozygous for a de novo ~1 Mb deletion encompassing the entire DPYD gene (Carter. 2010. PubMed ID: 21114665; Noor et al. 2010. PubMed ID: 20844286). In vitro experimental studies have shown that PTCHD1 protein carrying the p.Ile173Val variant is expressed at levels comparable to wild type and localizes properly to the cell membrane; however, additional experiments to assess possible impacts on protein function were not performed (Halewa et al. 2021. PubMed ID: 33856728). This variant is reported in 0.084% of alleles in individuals of South Asian descent in gnomAD. Although we suspect that this variant may be benign, the clinical significance of this variant is uncertain at this time due to the absence of conclusive functional and genetic evidence. - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2020 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at